Summary:

Presentation from Dr. Fatma Dedeoglu: Weaning Therapy

Summary:

Presentation from Dr. Bas Vastert: Biomarker-Guided Treatment-And-Stop_Strategy for Recombinat IL-1Receptor Antagonist (anakinra) in systemic Juvenile Idiopathic Arthritis

Summary:

Presentation from Dr. Michael Ombrello: What is the role of HLA DRB1*15 in Still's disease

Summary:

Presentation from Dr. Mariana Marques: Recent discovery in genomics of SJIA

Summary:

Presentation from Dr. Randy Cron: Clinical Utility of Genetics in systemic JIA

Summary:

Presentation from Dr. Lauren Henderson: recognizing and Treating Lung Disease in Systemic Juvenile idiophatic Arthritis

Summary:

Presentation from Dr. Claudia Bracaglia: Monitoring and Treating Lung Disease in Still's Disease

Summary:

Presentation from Dr. Grant Schulert: Criteria to consider BMT

Summary:

Presentaton from Dr. Juliana Silva: Long Term outcomes of Allogeneic HSCT for severe, refractory Juvenile Idiopathic Arthritis

Summary:

Presentation from Dr. Jim Connelly: Immune Reconstitution after Bone Marrow Transplant

Summary:

Presentation from Dr. Rebecca Marsh: BMT: How does it work and when it can be considered?

Summary:

Patient perspective about BMT in SJIA: Presentation from Luciana Pereira

Summary:

International Perspective: Presentation from dr Bruno Fautrel: Treating Refractory Adult Still's Patients

Summary:

International Perspective: Presentation from Dr. Juan Manuel Mosquera, Spain: Refractory disease (Still’s +/- MAS)

Summary:

International perspectives (China): Presentation from Dr. Caifeng Li

Summary:

International perspectives (Brazil): Presentation from Dr. Maria Teresa Terreri

Summary:

Presentation from Dr. Nadrendra Bagri: International perspectives (India)

Summary:

Presentation from Dr. Fabrizzio de Benedeti: Clinical Trials in Still's Disease (sJIA/AOSD)

Summary:

Presentation from Dr. Alexei Grom: SJIA with relapsing MAS

Summary:

Presentation from Dr. Ed Behrens: Treatment Paterns and Outcomes in Patients with Macrophage Activation Syndrome Secondary to Still's Disease Treated with Emapalumab

Summary:

Presentation from Dr. Paul brogan: Systemic Juvenile Idiopathic Arthritis: resistant disease, UK experience

Summary:

Presentation from Dr. Grant Schulert: The Changing face of SJIA.

Summary:

Summary:

This paper discusses recent findings on hematopoietic stem cell transplantation (HSCT) in patients with refractory systemic juvenile idiopathic arthritis (SJIA) and associated lung disease. It encompasses insights from case studies, optimal timing for procedures, and the management of complications to improve patient outcomes. Long-term follow-ups post-HSCT show promising results, but highlight the need for more data to determine the best candidate profile.